Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00676715||Active, not recruiting
|A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis||
||220||All||18 Years to 55 Years (Adult)||NCT00676715||ACT4422g
|July 31, 2008||March 9, 2012||December 10, 2020||May 13, 2008||June 19, 2018||May 11, 2017||